Cargando…

Incorporating genetics into the identification and treatment of Idiopathic Pulmonary Fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis, the most common form of idiopathic interstitial pneumonia, is characterized by progressive, irreversible scarring of the lung parenchyma. Idiopathic pulmonary fibrosis has a poor prognosis, and there are no medical therapies available that have been shown t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathai, Susan K., Yang, Ivana V., Schwarz, Marvin I., Schwartz, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581155/ https://www.ncbi.nlm.nih.gov/pubmed/26400796 http://dx.doi.org/10.1186/s12916-015-0434-0

Ejemplares similares

Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
por: Kaur, Amarpreet, et al.
Publicado: (2017)

Idiopathic pulmonary fibrosis and cancer: do they really look similar?
por: Vancheri, Carlo
Publicado: (2015)

The need for patient-centred clinical research in idiopathic pulmonary fibrosis
por: Russell, Anne-Marie, et al.
Publicado: (2015)

Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?
por: Nathan, Steven D, et al.
Publicado: (2014)

Idiopathic Pulmonary Fibrosis: A Systemic Disease?
por: Man, Luo, et al.
Publicado: (2017)

Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
por: Brereton, Christopher J., et al.
Publicado: (2020)

Familial and sporadic idiopathic pulmonary fibrosis: making the diagnosis from peripheral blood
por: Meltzer, Eric B, et al.
Publicado: (2014)

Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
por: Suarez-Cuartin, Guillermo, et al.
Publicado: (2020)

Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
por: Suarez-Cuartin, Guillermo, et al.
Publicado: (2019)

The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium
por: Seibold, Max A., et al.
Publicado: (2013)

The Peripheral Blood Transcriptome Identifies the Presence and Extent of Disease in Idiopathic Pulmonary Fibrosis
por: Yang, Ivana V., et al.
Publicado: (2012)

Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis
por: Michalski, Jacob E, et al.
Publicado: (2021)

Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF)
por: Boon, Kathy, et al.
Publicado: (2009)

The treatment of idiopathic pulmonary fibrosis
por: Woodcock, Hannah V., et al.
Publicado: (2014)

Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis
por: Montesi, Sydney B, et al.
Publicado: (2014)

Molecular genetics of idiopathic pulmonary fibrosis
por: Mustafin, R.N.
Publicado: (2022)

Spatially distinct molecular patterns of gene expression in idiopathic pulmonary fibrosis
por: Blumhagen, Rachel Z., et al.
Publicado: (2023)

Treatment of Idiopathic Pulmonary Fibrosis
por: Abuserewa, Sherif T, et al.
Publicado: (2021)

Identification of targetable kinases in idiopathic pulmonary fibrosis
por: Higo, Hisao, et al.
Publicado: (2022)

Recent advances in the genetics of idiopathic pulmonary fibrosis
por: Spagnolo, Paolo, et al.
Publicado: (2023)

The identification of metabolism-related subtypes and potential treatments for idiopathic pulmonary fibrosis
por: Yang, Changqing, et al.
Publicado: (2023)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Idiopathic Pulmonary Fibrosis: Treatment and Prognosis
por: Fujimoto, Hajime, et al.
Publicado: (2016)

Overlapping of Pulmonary Fibrosis of Postacute COVID-19 Syndrome and Tuberculosis in the Helminth Coinfection Setting in Sub-Saharan Africa
por: Fonte, Luis, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis: Current and future treatment
por: Glass, Daniel S., et al.
Publicado: (2022)

Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective
por: Papiris, Spyros A., et al.
Publicado: (2022)

Genetic overlap between idiopathic pulmonary fibrosis and COVID−19
por: Allen, Richard J, et al.
Publicado: (2022)

Incorporating mass casualty incidents training in surgical education program
por: Joshi, Anip, et al.
Publicado: (2022)

Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension
por: Parcesepe, Gina, et al.
Publicado: (2023)

Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis
por: Kraven, Luke M, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis
por: Dhindsa, Ryan S., et al.
Publicado: (2021)

Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
por: Chen, I-Chen, et al.
Publicado: (2022)

Update on diagnosis and treatment of idiopathic pulmonary fibrosis
por: Baddini-Martinez, José, et al.
Publicado: (2015)

The changing treatment landscape in idiopathic pulmonary fibrosis
por: Costabel, Ulrich
Publicado: (2015)

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
por: Amaral, Alexandre Franco, et al.
Publicado: (2023)

Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study
por: Nakanishi, Tomoko, et al.
Publicado: (2022)

Identification and Validation of Aging-Related Genes in Idiopathic Pulmonary Fibrosis
por: He, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lhmc5jak3mpd6b70arn5240qpk